Adcendo

📢 On Wednesday April 9th, our Head of BD James Feng Wang, will be speaking at the BioVerse Webinar to share insights on the exciting Asia-Europe Business Development and Licensing Boom. We look forward to a great discussion! Register via this link to join the webinar: https://lnkd.in/eeHX89ZJ InScienceWeTrust Community BioSpark Group #Biotech #Cancer #ADC #LifeSciences

📢 Our CEO Michael Pehl and CFO Fang Z. N. will be presenting at the Stifel 2025 Virtual Targeted Oncology Forum on Tuesday, April 8th. Tune in using the link below! https://bit.ly/43CAYyr #Biotech #Cancer #ADC #LifeSciences

✨We are delighted to welcome Serafino Pantano as VP, Head of Translational Medicine and Diagnostics at Adcendo.   Serafino brings extensive experience in precision and translational medicine. His expertise will be instrumental as we advance our innovative pipeline of antibody-drug conjugates (ADCs) for cancer patients with unmet medical needs. 🔬   A warm welcome to the team, Serafino!   If you are also passionate about improving treatment options for cancer patients and interested in joining our team, please follow our LinkedIn page for updates and open positions.   #Adcendo #NewHire #CancerResearch #ADCs #TranslationalMedicine #WeAreGrowing

📢 Today, at the Van Lanschot Kempen Life Sciences Conference in Amsterdam, our CEO Michael Pehl will be taking part in a plenary panel discussion at 11:30 CET on the subject of “ADCs done different”. See you there! 

📢PRESS RELEASE 📢 We are thrilled to announce three key changes to the Adcendo Board and Executive Leadership team! - Laura Shawver, Ph.D. – Chair of the Board - Roy Baynes, M.D., Ph.D. – Independent Board Director - Fang Z. N., Pharm.D. – Chief Financial Officer Michael Pehl, CEO of Adcendo, comments: “Laura's visionary outlook and strategic acumen, combined with Roy’s wealth of clinical development experience and strong track record, and Fang's financial and operations expertise, will be invaluable as we execute on all our corporate and clinical objectives. On behalf of the entire management team, it is a great privilege to work alongside all these high caliber individuals as we pursue our mission to transform the lives of patients with high unmet need cancers.”   Additionally, as part of our global expansion strategy, we are excited to announce the anticipated opening of a U.S. office in Boston, MA.   Read more here: https://lnkd.in/dXQPfifQ #ADC #Oncology #Biotech #LifeSciences

✨We are excited to welcome Jared Lurk, Pharm.D. as Vice President of U.S. Medical Affairs. Jared will be part of our growing US team, reinforcing our ambition to become a leading international ADC company.   Jared brings extensive experience in medical affairs, clinical development, and scientific relationship building. His expertise will be instrumental as we advance our innovative pipeline of antibody-drug conjugates (ADCs) for cancer patients with unmet medical needs.   We are thrilled to have you with us at this journey, Jared! 🌎   If you are also passionate about improving treatment options for cancer patients and interested in joining our team, please follow our LinkedIn page for updates and open positions. #Adcendo #NewHire #CancerResearch #ADCs #MedicalAffairs #WeAreGrowing  

📢 Join us at the Nordic-American Healthcare Conference! 📢 The Adcendo team is excited to be in New York to present at the Nordic-American Healthcare Conference on Thursday, March 27th. We hope to see you there!    #biotech #cancer #ADC #LifeSciences

✨ We are thrilled to welcome Sarah Berardini as Director, Site Engagement & Clinical Operations at Adcendo. Sarah will be overseeing our clinical activities in Australia, underscoring our ambition to become a leading, international ADC company. Sarah brings extensive experience in Clinical Operations and Project Management. Her expertise will be instrumental as we conduct our clinical trials with antibody-drug conjugates (ADCs) for cancer patients with unmet medical needs. We are super excited to welcome you on this journey, Sarah! 🌏 If you are also passionate about improving treatment options for cancer patients and want to join our team, please follow our LinkedIn page for updates and information about open positions. #Adcendo #NewHire #CancerResearch #ADCs #ClinicalOperations #WeAreGrowing

📢 Join us at #BioEurope Spring! 📢   We are thrilled to be in Milan for BIO-Europe Spring this year. Get in touch to arrange a meeting with the Adcendo team – we hope to see you there for insightful discussions and updates on our unique ADC pipeline!   #biotech #cancer #ADC #LifeSciences

✨ We are delighted to welcome Anne-Dorte Loftheim, who has joined us as Clinical Trial Supply Manager. Anne-Dorte brings extensive experience in clinical trial supply management. Her strong expertise will be a great addition to our CMC department as we advance our innovative pipeline of antibody-drug conjugates (ADCs) for cancer patients with unmet medical needs. 🔬 A warm welcome to Adcendo, Anne-Dorte! If you are also passionate about improving treatment options for cancer patients and want to join our team, please follow our LinkedIn page for updates and information about open positions. #Adcendo #NewHire #CancerResearch #ADCs #ClinicalTrialSupply #QualityAssurance #WeAreGrowing